Key result
High Back-Referral Program implementation linked to ~18.2-fold higher medication adherence in hypertension.
Why the study?
Medication adherence among patients with hypertension remains a major challenge despite implementation of the BPJS Kesehatan Back-Referral Program to ensure continuity of care.
Does the implementation of the BPJS Kesehatan Back-Referral Program improve medication adherence in hypertensive patients?
Cross-Sectional (n=79)
No
Does the implementation of the BPJS Kesehatan Back-Referral Program improve medication adherence in hypertensive patients?
Odds Ratio: 18.2 (95% CI 5.144–64.395)
Absolute Event Rate: 91.2% vs 36.4%
p-value: p=0.001
A high level of implementation of the BPJS Kesehatan Back-Referral Program is strongly associated with better medication adherence in hypertensive patients.
Supports exploring high-fidelity referral programs for hypertension adherence; cross-sectional data leave causality and generalizability open.
Hypertension is a chronic disease that requires long-term treatment; however, medication adherence among patients with hypertension remains a major challenge in achieving optimal blood pressure control and preventing complications. Although the BPJS Kesehatan Back-Referral Program (BRP) has been implemented to ensure continuity of care for patients with chronic diseases, many patients with hypertension remain non-adherent to their prescribed medication. This study aimed to analyze the relationship between the implementation of the BPJS Kesehatan Back-Referral Program (BRP) and medication adherence among patients with hypertension at Meurebo Community Health Center, West Aceh Regency. This study employed a quantitative approach using a cross-sectional design. The study population consisted of 365 hypertensive patients enrolled in the BPJS Kesehatan Back-Referral Program, and a sample of 79 respondents was selected using an accidental sampling technique. Data were collected through structured questionnaire-based interviews and analyzed using the Chi-square test with a 95% confidence level. The results showed that 72.2% of respondents experienced a high level of Back-Referral Program implementation, while 75.9% demonstrated good medication adherence. Bivariate analysis revealed a statistically significant relationship between the Back-Referral Program and medication adherence among patients with hypertension (p = 0.001). Patients with a high level of Back-Referral Program implementation were 18.2 times more likely to adhere to their medication than those with a moderate level of program implementation (OR = 18.200; 95% CI = 5.144–64.395). It can be concluded that the implementation of the BPJS Kesehatan Back-Referral Program was significantly associated with medication adherence among patients with hypertension. Optimizing the implementation of the Back-Referral Program through improved healthcare services, health education, and routine patient monitoring is expected to enhance medication adherence and support sustainable hypertension management.
No takes yet. Share an insight, caveat, or question.
Masriana et al. (2026) conducted a cross-sectional in Hypertension (n=79). High level of BPJS Kesehatan Back-Referral Program (PRB) implementation vs. Moderate level of program implementation was evaluated on Medication adherence (OR 18.200, 95% CI 5.144-64.395, p=0.001). A high level of Back-Referral Program implementation was associated with an 18.2-fold higher likelihood of medication adherence in hypertensive patients compared to moderate implementation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: